Related Experiment Video
Updated: Jun 10, 2025
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
Interfering with KIR and NKG2A immune checkpoint axes to unleash NK cell immunotherapy
Nicky A Beelen1, Vera T C Valckx1, Gerard M J Bos2
1Department of Internal Medicine, Division of Hematology, Maastricht University Medical Center+, Maastricht, the Netherlands; GROW-School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands; Department of Transplantation Immunology, Tissue Typing Laboratory, Maastricht University Medical Center+, Maastricht, the Netherlands.
Abstract:
Due to their intrinsic ability to eliminate malignant cells, natural killer (NK) cells emerge as a promising immunotherapy for cancer. While clinical studies have affirmed the safety of NK cell infusions and combination therapies have demonstrated encouraging outcomes in hematological malignancies, the efficacy of NK cell immunotherapeutic interventions remains heterogeneous across patient cohorts. Moreover, the implementation of NK cell immunotherapy in solid tumors presents notable challenges. Interfering with key NK cell inhibitory signaling pathways by targeting inhibitory killer cell immunoglobulin-like receptors (KIRs) and CD94/NK group 2 member A (NKG2A), holds promise for unleashing the full potential of NK cell-based immunotherapy. In this review, we provide an overview of the current approaches for interfering with inhibitory KIR and NKG2A signaling, exploring a selection of the multitude of combination strategies available. We discuss the significance of maintaining the delicate balance between achieving optimal suppression of NK cell inhibition and ensuring effective activation of anti-tumor effector function, while preserving the favorable safety profiles. The consideration of strategies to modulate inhibitory signaling pathways associated with KIR and NKG2A presents promising avenues for enhancing the efficacy of NK cell immunotherapy.
Insights
Natural killer (NK) cell immunotherapy shows promise for cancer treatment. Targeting inhibitory pathways like KIR and NKG2A can enhance NK cell effectiveness against tumors, improving patient outcomes.
Area of Science:
- Immunology
- Cancer Biology
- Immunotherapy
Background:
- Natural killer (NK) cells possess inherent anti-cancer properties, making them a focus for cancer immunotherapy.
- While NK cell infusions are safe and show promise in blood cancers, their efficacy varies, and challenges exist in treating solid tumors.
Purpose of the Study:
- To review current strategies for modulating NK cell inhibitory signaling pathways, specifically targeting killer cell immunoglobulin-like receptors (KIRs) and CD94/NK group 2 member A (NKG2A).
- To explore combination strategies that enhance NK cell-based immunotherapy efficacy.
Main Methods:
- Review of existing literature on NK cell inhibitory receptor signaling.
- Analysis of combination therapies targeting KIR and NKG2A pathways.
- Discussion of balancing NK cell inhibition suppression with anti-tumor effector function activation.
Main Results:
- Interfering with KIR and NKG2A inhibitory signaling offers a promising approach to enhance NK cell immunotherapy.
- Various combination strategies can be employed to modulate these pathways.
- Maintaining a balance between inhibiting NK cell suppression and activating anti-tumor functions is crucial for safety and efficacy.
Conclusions:
- Modulating KIR and NKG2A inhibitory signaling pathways presents a viable strategy to improve NK cell immunotherapy efficacy.
- Careful consideration of combination approaches is needed to optimize anti-tumor responses while ensuring safety.
- Further research into these strategies holds potential for advancing cancer treatment.
More Related Videos
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy
01:28Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...